An on-site cascading vaccine breaks tumor immune evasion and elicits systemic immunity.

Tumor cells evade immunosurveillance through a defense system conceptualized as camouflage, coercion, and cytoprotection. Therapeutic success requires simultaneous targeting of them all to restore antitumor immunosurveillance. Furthermore, the induct…

Preview only. Read the full abstract at the source